According to MarketsandMarkets™,The agricultural robots market is estimated at USD 17.73 billion in 2025 and is projected to reach USD 56.26 billion by 2030, at a CAGR of 26.0% from 2025 to 2030. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg The agricultural robots market is driven by the growing adoption of automation and precision farming solutions, which aim to improve operational […]

(NASDAQ:PWP), Financial Overview – Third Quarter Revenues of $165 Million, Down 41% From a Record a Year Ago Adjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.13; GAAP Diluted EPS of $0.08 Financial Overview – Nine Months Revenues of $532 Million, Down 18% From a Record a Year

Expert researchers and clinicians from the Leon H. Charney Division of Cardiologyat NYU Langone will present practice-changing studies, translational research, and clinical insights at the 2025 American Heart Association's (AHA's) Scientific Sessions, held from November 7 to 10 in New Orleans. Topics include diving into inflammation's role in heart disease, management of a type of

Perella Weinberg Reports Third Quarter 2025 Results GlobeNewswire November 07, 2025 Financial Overview – Third Quarter Revenues of $165 Million, Down 41% From a Record a Year Ago Adjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 Million Adjusted EPS of $0.13; GAAP Diluted EPS of $0.08 Financial Overview – Nine Months Revenues

The investigational device evaluated in the trial, previously known as the GORE® VIAFORT Vascular Stent, will now be referred to as the GORE® VIABAHN® FORTEGRA Venous Stent. CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates' medical business (Gore) today announced trial results evaluating the investigational GORE® VIABAHN®

The board of trustees (the “Board”) of NXG Cushing® Midstream Energy Fund (NYSE: SRV) (the “Fund”) has approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund's common shares (the “Common Shareholders”) of beneficial interest, par value $0.001 per share (“Common Shares”), as of the record date, entitling the

In the presence of His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes' Affairs, and His Excellency Dr. Thani bin Ahmed Al Zeyoudi, Minister of Foreign Trade, Silal, Abu Dhabi's leading agri-food and technology company, signed a landmark joint venture (JV) agreement with

Dubai, UAE, Nov. 07, 2025 (GLOBE NEWSWIRE) — Prophex, the first perpetual prediction market, issued a security update following a brief compromise of its official X account on November 1 (UTC). During the short window, three scam posts were published from the account promoting a counterfeit token. The incident was rapidly contained, core systems were

Prophex Shows Resilience After Attack From Hackers Following High-Profile CZ Engagement Prophex confirms incident contained; testnet launch timeline unchanged GlobeNewswire November 07, 2025 Dubai, UAE, Nov. 07, 2025 (GLOBE NEWSWIRE) — Prophex, the first perpetual prediction market, issued a security update following a brief compromise of its official X account on November 1 (UTC). During

(NasdaqGM:ANIP), Record quarterly net revenues of $227.8 million, an increase of 53.6% year-over-year Purified Cortrophin(R) Gel net revenues of $101.9 million, an increase of 93.8% year-over-year Record quarterly adjusted non-GAAP EBITDA of $59.6 million, an increase of 69.8% year-over-year Diluted GAAP income per share of $1.13 and record adjusted non-GAAP diluted earnings per share of